Cel-Sci Corporation Information and Competitive Analysis

Cel-Sci Corporation is a biotechnology company that has been around since 1983. It's been over 40 years of experience in developing and commercializing innovative cancer treatments.

The company's focus is on immunotherapy, specifically the use of its proprietary Multi-Cancer Vaccine technology. This technology has shown promise in treating various types of cancer.

Cel-Sci has a strong presence in the biotech industry, with a market capitalization of over $100 million. It's also listed on the NASDAQ stock exchange, making it a publicly traded company.

Broaden your view: Wyatt Technology Corporation

At Cel-Sci Corporation, the leadership team has a deep understanding of the company's history and operations. Geert Kersten has been leading the company since 1995 and has been with Cel-Sci from its early days in 1987.

Patricia B. Prichep, with over 30 years of experience in business operations and administration, took on the role of Chief Financial and Operations Officer in 2024. John Cipriano brings over 30 years of experience in biotech and pharmaceutical companies to his position as Senior Vice President of Regulatory Affairs.

Dr. Selvaggi has been Acting Chief Medical Officer since May 2024, with extensive experience in clinical development in the pharmaceutical industry in oncology.

Recommended read: BioMarin Pharmaceutical

CEL-SCI's leadership team has a combined experience of over 100 years in the biotech and pharmaceutical industries. Geert Kersten has been at the helm since 1995, with a tenure that spans over 25 years.

Geert Kersten's experience is complemented by Eyal Talor, who joined CEL-SCI in 1993 and was promoted to Chief Scientific Officer in 2009. He brings a wealth of knowledge in research and manufacturing.

Patricia B. Prichep, with over 30 years of experience in business operations and administration, took on the role of Chief Financial and Operations Officer in 2024. She has been with the company since 1992.

John Cipriano, a seasoned professional with over 30 years of experience in biotech and pharmaceutical companies, serves as CEL-SCI's Senior Vice President of Regulatory Affairs. His expertise is invaluable to the company's success.

Dr. Selvaggi has been the Acting Chief Medical Officer since May 2024, bringing extensive experience in early and late-stage clinical development in oncology.

The Board of Directors plays a crucial role in guiding the direction of CEL-SCI.

Mr. Watson has been a director of CEL-SCI since December 2017.

He currently serves as the Executive Chairperson and CEO of Health Gorilla, a position he likely brings valuable experience to the table.

Mr. Baillavoine has been a Director of CEL-SCI since June 2015.

Since 2017, he has also been the Director, Head of Pericles Group UK, a subsidiary of the Paris-based leading French consulting firm.

Cel-SCI Corporation offers a comprehensive benefits package to its employees. Medical, dental, and vision insurance are all included, providing essential coverage for employees and their families.

CEL-SCI also offers long term disability and life insurance, as well as AD&D insurance, giving employees peace of mind in times of need. Additionally, the company provides a 401(k) Plan, where each participant's contribution is matched by CEL-SCI with shares of common stock.

The benefits package also includes Flexible Spending Accounts (FSA), which allow pre-tax deductions for dependent care, unreimbursed medical expenses, and medical premiums. Stock Option Plans and a Tuition Reimbursement Plan are also available to support employees' professional and personal growth.

Here are the benefits and perks offered by Cel-SCI Corporation:

Cel Sci offers a comprehensive benefits package that includes medical, dental, and vision insurance to ensure employees' physical and mental well-being.

Their 401(k) Plan is particularly notable, as it matches participants' contributions with shares of common stock, providing a unique opportunity for employees to grow their retirement savings.

Long Term Disability insurance and Life and AD&D insurance are also included, providing financial security in case of unexpected events.

The company also offers Flexible Spending Accounts (FSAs), which allow employees to make pre-tax deductions for dependent care, unreimbursed medical expenses, and medical premiums.

Other benefits include Stock Option Plans, Tuition Reimbursement Plan, and AFLAC, which can help employees achieve their long-term goals and financial stability.

Here's a breakdown of the benefits package:

As a Quality Assurance Document Manager, you'll have the ability to efficiently manage and organize documents, reducing the risk of errors and miscommunication.

This role is perfect for individuals who are detail-oriented and enjoy working with documents.

With the ability to create and maintain documentation templates, you'll be able to streamline processes and ensure consistency across teams.

In this role, you'll also be responsible for reviewing and updating documents to ensure they remain accurate and compliant.

Having a Quality Assurance Document Manager on your team can significantly reduce the time spent searching for documents and improve overall productivity.

By implementing a centralized document management system, you can easily track changes and revisions, and ensure that all team members have access to the most up-to-date information.

Cel-Sci Corporation offers a range of career opportunities, from research and development to sales and marketing. The company is actively seeking talented individuals to join its team.

As a biotechnology company, Cel-Sci Corporation requires professionals with expertise in areas such as molecular biology, biochemistry, and immunology. With a focus on developing innovative cancer treatments, the company needs scientists and researchers who can contribute to its mission.

By joining Cel-Sci Corporation, you can be part of a dynamic team that is dedicated to improving patient outcomes and advancing the field of cancer research.

On a similar theme: American Research and Development Corporation

A Facilities Engineer is responsible for ensuring the smooth operation of buildings and facilities. They oversee maintenance, repairs, and upgrades to keep everything running efficiently.

Their work involves managing budgets, supervising teams, and coordinating with other departments to resolve issues. This might include resolving conflicts between tenants or managing emergency situations.

Facilities Engineers often have a background in engineering or a related field, with a focus on mechanical systems, electrical systems, or architecture. A bachelor's degree in a relevant field is typically required for this role.

Their work can take them indoors and outdoors, from inspecting HVAC systems to inspecting the grounds and exterior of buildings. They need to be comfortable with heights and able to navigate confined spaces.

In addition to technical skills, Facilities Engineers need strong communication and problem-solving skills to work effectively with colleagues and stakeholders.

Suggestion: ImClone Systems

As an IT Specialist in the GMP (Good Manufacturing Practice) industry, you'll be working with strict regulations to ensure the quality and safety of pharmaceutical products.

GMP is a set of guidelines that ensures the quality and safety of pharmaceutical products by controlling the manufacturing process.

In this role, you'll be responsible for implementing and maintaining IT systems that meet GMP standards.

You'll need to have a strong understanding of GMP regulations, such as those outlined in the FDA's 21 CFR Part 11, which governs electronic records and signatures.

Your primary goal will be to ensure that IT systems are compliant with GMP regulations, which can be a challenging task.

To succeed in this role, you'll need to have excellent problem-solving skills and be able to work well under pressure.

You'll also need to be familiar with IT systems such as LIMS (Laboratory Information Management System) and ERP (Enterprise Resource Planning) systems, which are commonly used in the pharmaceutical industry.

In addition to technical skills, you'll need to have excellent communication skills to work effectively with cross-functional teams.

A bachelor's degree in a relevant field, such as computer science or information technology, is typically required for this role.

Broaden your view: Credit Information Corporation

Cel-Sci Corporation is a biotechnology company founded in 1981 by George E. Wolford. It's based in Virginia, USA.

The company has a long history of developing innovative cancer treatments, with a focus on immunotherapy.

Cel-Sci's lead product, Multikine, is a therapeutic cancer vaccine designed to stimulate the immune system to attack cancer cells.

Their research has shown promising results in various clinical trials, with one study demonstrating a significant increase in survival rates for patients with head and neck cancer.

CEL-SCI Corp is actively conducting clinical trials to advance its product pipeline.

The company's clinical trials are designed to determine the go-to-market proposition, which will inform its commercialization strategy.

CEL-SCI Corp's clinical operations, recruitment, and trial strategy are crucial components of its product development.

The company's products are being evaluated in clinical trials to determine which ones will be commercialized.

CEL-SCI Corp's clinical trials will help the company contend with shifting product portfolios and stay ahead of the market.

Cel-Sci Corporation operates as a public entity, which suggests that it has a certain level of transparency and accountability.

The company is headquartered in Vienna, Virginia, which may provide a strategic advantage in terms of access to resources and talent.

Cel-Sci Corporation has a relatively small team of 43 employees.

In comparison, some of its competitors have significantly larger teams, such as Adicet Bio Inc with 152 employees.

Here is a summary of the number of employees across the companies:

All of the companies mentioned are public entities, which may indicate that they have a certain level of visibility and accountability.

Cel-Sci has experience with arbitration, winning a 4.5-year-long arbitration suit against CRO InVentiv Health in 2018.

The arbitrator awarded Cel-Sci $2.9 million in damages due to the CRO's failure to enroll the required number of patients, which delayed the clinical development of Multikine.

This experience likely taught Cel-Sci the importance of clear contracts and timely patient enrollment in clinical trials.

The arbitration victory also had a positive impact on Cel-Sci's business, allowing them to advance to Phase III of their head and neck cancer study after the FDA lifted their clinical hold in August 2017.

If this caught your attention, see: KCR CRO